Bone Biologics (BBLGW) Equity Ratio (2016 - 2017)
Bone Biologics (BBLGW) has disclosed Equity Ratio for 2 consecutive years, with 6.1 as the latest value for Q3 2017.
- Quarterly Equity Ratio rose 32.39% to 6.1 in Q3 2017 from the year-ago period, while the trailing twelve-month figure was 6.1 through Sep 2017, up 32.39% year-over-year, with the annual reading at 11.93 for FY2016, N/A changed from the prior year.
- Equity Ratio for Q3 2017 was 6.1 at Bone Biologics, up from 11.14 in the prior quarter.
- The five-year high for Equity Ratio was 0.75 in Q1 2016, with the low at 11.93 in Q4 2016.